LINC01090

Across TCGA pan-cancer cohorts, LINC01090 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01090 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01090 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01090 expression acts as an unfavorable survival marker, although some lineages such as CHOL and BRCA show a favorable association.

KIRC, COAD, and LIHC are the cancer types where LINC01090 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.575	0.725	<.001	112	view →
COAD	OS	Tertile	II,III,IV	0.649	0.823	.003	81	view →
LIHC	OS	Tertile	All	0.512	0.748	<.001	54	view →
CHOL	DFS	Quartile	All	0.798	0.052	.004	30	view →
UVM	OS	Tertile	All	0.589	0.944	.012	27	view →
ESCA	OS	Median	All	0.629	1.000	.012	24	view →
SKCM	OS	Median	III,IV	0.707	0.845	.008	20	view →
PAAD	DFS	Median	All	0.180	0.400	.001	19	view →
BRCA	DFS	Quartile	All	0.590	0.490	.020	16	view →
THCA	OS	Tertile	IV	0.832	1.000	.035	14	view →
CESC	DFS	Median	III,IV	0.672	0.243	.013	10	view →
READ	DFS	Tertile	III,IV	0.438	0.767	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01090–KIRC (OS)

Open the KIRC breakdown →